Investing Profile

Jim Trenkle

InvestorVC
Head of Investments at Sanofi Ventures
sanofiventures.com/team/index...Cambridge, Massachusetts
Photo of Jim Trenkle, Investor at Sanofi Ventures
cb
$5.0M - $10.0M
$7.5M
6
CompanyStageDateRound SizeTotal Raised
Convergent Therapeutics
Series ASep 2024$40M
$130M
Co-investors: Jake Simson (RA Capital)
MapLight Therapeutics
Series COct 2023$230M
$230M
Therini Bio
Series AApr 2023$36M
SeedMay 2021$17M
$62M
Co-investors: Laurence Barker (SV Health Investors), Mike Ross (SV Health Investors), Pascal Levensohn (Dolby Family Ventures), Houman Ashrafian (SV Health Investors)
ROME Therapeutics
Series BSep 2021$77M
$130M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Kristina Burow (ARCH Venture Partners), Steve Kafka (Section 32)
Glycomine
Series BJun 2021$35M
$35M
Co-investors: Bali Muralidhar (Abingworth), Niall O’Donnell (RiverVest)